|
|
| Line 1: |
Line 1: |
| ==[[DCE-MRI]]==
| | *[[Media:Claims.doc|SubmittedDocs]] |
| ''<one or two line summary of the project/goal>''
| |
| | |
| | |
| ==[[FDG-PET]]==
| |
| ''<one or two line summary of the project/goal>''
| |
| | |
| | |
| ==[[Volumetric CT]]==
| |
| Volumetric CT-based biomarkers for parenchymal mass (lung nodule) response assessment has been selected to provide a concrete target to start on.
| |
| | |
| Work is focused on establishing a QIBA framework to organize and pursue the research-oriented groundwork and the standards-oriented profile development/implementation necessary to put such biomarkers into practice in the hands of clinical and pharma users.
| |